カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のPD-1＆PD-L1モノクローナル抗体市場2022年：PD-1、 PD-L1

◆英語タイトル：Global PD-1 and PD-L1 Monoclonal Antibody Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8927 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：106 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

PD-1＆PD-L1モノクローナル抗体市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のPD-1＆PD-L1モノクローナル抗体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

PD-1＆PD-L1モノクローナル抗体市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・PD-1、 PD-L1

用途別セグメントは次のように区分されます。
・肺がん、肝臓がん、食道がん、胃がん、鼻咽頭がん、頭頸部がん、その他

世界のPD-1＆PD-L1モノクローナル抗体市場の主要な市場プレーヤーは以下のとおりです。
・Merk、Bristol-Myers Squibb Company、Roche、Pfizer、AstraZeneca、Junshi Biosciences、Innovent、Hengrui、BeiGene、Alphamab Oncology、Cstone、Akeso

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、PD-1＆PD-L1モノクローナル抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なPD-1＆PD-L1モノクローナル抗体メーカーの企業概要、2019年～2022年までのPD-1＆PD-L1モノクローナル抗体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なPD-1＆PD-L1モノクローナル抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別PD-1＆PD-L1モノクローナル抗体の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのPD-1＆PD-L1モノクローナル抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのPD-1＆PD-L1モノクローナル抗体市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびPD-1＆PD-L1モノクローナル抗体の産業チェーンを掲載しています。
・第13、14、15章では、PD-1＆PD-L1モノクローナル抗体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merk、Bristol-Myers Squibb Company、Roche、Pfizer、AstraZeneca、Junshi Biosciences、Innovent、Hengrui、BeiGene、Alphamab Oncology、Cstone、Akeso
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：PD-1、 PD-L1
・用途別分析2017年-2028年：肺がん、肝臓がん、食道がん、胃がん、鼻咽頭がん、頭頸部がん、その他
・PD-1＆PD-L1モノクローナル抗体の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・PD-1＆PD-L1モノクローナル抗体のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・PD-1＆PD-L1モノクローナル抗体のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・PD-1＆PD-L1モノクローナル抗体の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・PD-1＆PD-L1モノクローナル抗体の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The PD-1 and PD-L1 Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PD-1 and PD-L1 Monoclonal Antibody market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Lung Cancer accounting for % of the PD-1 and PD-L1 Monoclonal Antibody global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PD-1 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PD-1 and PD-L1 Monoclonal Antibody include Merk, Bristol-Myers Squibb Company, Roche, Pfizer, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PD-1 and PD-L1 Monoclonal Antibody market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PD-1
PD-L1
Market segment by Application can be divided into
Lung Cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Nasopharyngeal Carcinoma
Head and Neck Cancer
Other
The key market players for global PD-1 and PD-L1 Monoclonal Antibody market are listed below:
Merk
Bristol-Myers Squibb Company
Roche
Pfizer
AstraZeneca
Junshi Biosciences
Innovent
Hengrui
BeiGene
Alphamab Oncology
Cstone
Akeso
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PD-1 and PD-L1 Monoclonal Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PD-1 and PD-L1 Monoclonal Antibody, with price, sales, revenue and global market share of PD-1 and PD-L1 Monoclonal Antibody from 2019 to 2022.
Chapter 3, the PD-1 and PD-L1 Monoclonal Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 and PD-L1 Monoclonal Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PD-1 and PD-L1 Monoclonal Antibody market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PD-1 and PD-L1 Monoclonal Antibody.
Chapter 13, 14, and 15, to describe PD-1 and PD-L1 Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 PD-1 and PD-L1 Monoclonal Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PD-1
1.2.3 PD-L1
1.3 Market Analysis by Application
1.3.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Lung Cancer
1.3.3 Liver Cancer
1.3.4 Esophageal Cancer
1.3.5 Gastric Cancer
1.3.6 Nasopharyngeal Carcinoma
1.3.7 Head and Neck Cancer
1.3.8 Other
1.4 Global PD-1 and PD-L1 Monoclonal Antibody Market Size & Forecast
1.4.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume (2017-2028)
1.4.3 Global PD-1 and PD-L1 Monoclonal Antibody Price (2017-2028)
1.5 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity Analysis
1.5.1 Global PD-1 and PD-L1 Monoclonal Antibody Total Production Capacity (2017-2028)
1.5.2 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PD-1 and PD-L1 Monoclonal Antibody Market Drivers
1.6.2 PD-1 and PD-L1 Monoclonal Antibody Market Restraints
1.6.3 PD-1 and PD-L1 Monoclonal Antibody Trends Analysis
2 Manufacturers Profiles
2.1 Merk
2.1.1 Merk Details
2.1.2 Merk Major Business
2.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Junshi Biosciences
2.6.1 Junshi Biosciences Details
2.6.2 Junshi Biosciences Major Business
2.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Innovent
2.7.1 Innovent Details
2.7.2 Innovent Major Business
2.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hengrui
2.8.1 Hengrui Details
2.8.2 Hengrui Major Business
2.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BeiGene
2.9.1 BeiGene Details
2.9.2 BeiGene Major Business
2.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Alphamab Oncology
2.10.1 Alphamab Oncology Details
2.10.2 Alphamab Oncology Major Business
2.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Cstone
2.11.1 Cstone Details
2.11.2 Cstone Major Business
2.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Akeso
2.12.1 Akeso Details
2.12.2 Akeso Major Business
2.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PD-1 and PD-L1 Monoclonal Antibody Breakdown Data by Manufacturer
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PD-1 and PD-L1 Monoclonal Antibody
3.4 Market Concentration Rate
3.4.1 Top 3 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2021
3.4.2 Top 6 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2021
3.5 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PD-1 and PD-L1 Monoclonal Antibody Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2017-2028)
4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2028)
4.2 North America PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.3 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.4 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.5 South America PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.6 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Type (2017-2028)
5.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2017-2028)
5.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Application (2017-2028)
6.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2017-2028)
6.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
7.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
7.3 North America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
7.3.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
7.3.2 North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
8.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
8.3 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
8.3.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
8.3.2 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
9.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
9.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
9.3.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
10.2 South America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
10.3 South America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
10.3.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
10.3.2 South America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
11.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
11.3 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
11.3.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PD-1 and PD-L1 Monoclonal Antibody and Key Manufacturers
12.2 Manufacturing Costs Percentage of PD-1 and PD-L1 Monoclonal Antibody
12.3 PD-1 and PD-L1 Monoclonal Antibody Production Process
12.4 PD-1 and PD-L1 Monoclonal Antibody Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PD-1 and PD-L1 Monoclonal Antibody Typical Distributors
13.3 PD-1 and PD-L1 Monoclonal Antibody Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merk Basic Information, Manufacturing Base and Competitors
Table 4. Merk Major Business
Table 5. Merk PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 6. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 10. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 14. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 18. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 22. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 24. Junshi Biosciences Major Business
Table 25. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 26. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Innovent Basic Information, Manufacturing Base and Competitors
Table 28. Innovent Major Business
Table 29. Innovent PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 30. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hengrui Basic Information, Manufacturing Base and Competitors
Table 32. Hengrui Major Business
Table 33. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 34. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. BeiGene Basic Information, Manufacturing Base and Competitors
Table 36. BeiGene Major Business
Table 37. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 38. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 40. Alphamab Oncology Major Business
Table 41. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 42. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Cstone Basic Information, Manufacturing Base and Competitors
Table 44. Cstone Major Business
Table 45. Cstone PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 46. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Akeso Basic Information, Manufacturing Base and Competitors
Table 48. Akeso Major Business
Table 49. Akeso PD-1 and PD-L1 Monoclonal Antibody Product and Services
Table 50. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 52. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in PD-1 and PD-L1 Monoclonal Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity by Company, (Units): 2020 VS 2021
Table 55. Head Office and PD-1 and PD-L1 Monoclonal Antibody Production Site of Key Manufacturer
Table 56. PD-1 and PD-L1 Monoclonal Antibody New Entrant and Capacity Expansion Plans
Table 57. PD-1 and PD-L1 Monoclonal Antibody Mergers & Acquisitions in the Past Five Years
Table 58. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022) & (Units)
Table 59. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2023-2028) & (Units)
Table 60. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022) & (USD Million)
Table 61. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2023-2028) & (USD Million)
Table 62. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
Table 63. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2023-2028) & (Units)
Table 64. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2017-2022) & (USD Million)
Table 65. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2023-2028) & (USD Million)
Table 66. Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2017-2022) & (US$/Unit)
Table 67. Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2023-2028) & (US$/Unit)
Table 68. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
Table 69. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2023-2028) & (Units)
Table 70. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2017-2022) & (USD Million)
Table 71. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2023-2028) & (USD Million)
Table 72. Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2017-2022) & (US$/Unit)
Table 73. Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2023-2028) & (US$/Unit)
Table 74. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)
Table 75. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2023-2028) & (Units)
Table 76. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & (USD Million)
Table 77. North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2023-2028) & (USD Million)
Table 78. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
Table 79. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2023-2028) & (Units)
Table 80. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
Table 81. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2023-2028) & (Units)
Table 82. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)
Table 83. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2023-2028) & (Units)
Table 84. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
Table 87. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2023-2028) & (Units)
Table 88. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
Table 89. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2023-2028) & (Units)
Table 90. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022) & (Units)
Table 91. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2023-2028) & (Units)
Table 92. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
Table 95. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2023-2028) & (Units)
Table 96. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
Table 97. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2023-2028) & (Units)
Table 98. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)
Table 99. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2023-2028) & (Units)
Table 100. South America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & (USD Million)
Table 101. South America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2023-2028) & (USD Million)
Table 102. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
Table 103. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2023-2028) & (Units)
Table 104. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
Table 105. South America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2023-2028) & (Units)
Table 106. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022) & (Units)
Table 107. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2023-2028) & (Units)
Table 108. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)
Table 111. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2023-2028) & (Units)
Table 112. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)
Table 113. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2023-2028) & (Units)
Table 114. PD-1 and PD-L1 Monoclonal Antibody Raw Material
Table 115. Key Manufacturers of PD-1 and PD-L1 Monoclonal Antibody Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. PD-1 and PD-L1 Monoclonal Antibody Typical Distributors
Table 119. PD-1 and PD-L1 Monoclonal Antibody Typical Customers
List of Figures
Figure 1. PD-1 and PD-L1 Monoclonal Antibody Picture
Figure 2. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type in 2021
Figure 3. PD-1
Figure 4. PD-L1
Figure 5. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application in 2021
Figure 6. Lung Cancer
Figure 7. Liver Cancer
Figure 8. Esophageal Cancer
Figure 9. Gastric Cancer
Figure 10. Nasopharyngeal Carcinoma
Figure 11. Head and Neck Cancer
Figure 12. Other
Figure 13. Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 14. Global PD-1 and PD-L1 Monoclonal Antibody Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global PD-1 and PD-L1 Monoclonal Antibody Sales (2017-2028) & (Units)
Figure 16. Global PD-1 and PD-L1 Monoclonal Antibody Price (2017-2028) & (US$/Unit)
Figure 17. Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity (2017-2028) & (Units)
Figure 18. Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. PD-1 and PD-L1 Monoclonal Antibody Market Drivers
Figure 20. PD-1 and PD-L1 Monoclonal Antibody Market Restraints
Figure 21. PD-1 and PD-L1 Monoclonal Antibody Market Trends
Figure 22. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Manufacturer in 2021
Figure 23. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Manufacturer in 2021
Figure 24. PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 PD-1 and PD-L1 Monoclonal Antibody Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 PD-1 and PD-L1 Monoclonal Antibody Manufacturer (Revenue) Market Share in 2021
Figure 27. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2028)
Figure 28. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2028)
Figure 29. North America PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028) & (USD Million)
Figure 30. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028) & (USD Million)
Figure 32. South America PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028) & (USD Million)
Figure 34. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 35. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2017-2028)
Figure 36. Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2017-2028) & (US$/Unit)
Figure 37. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 38. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2017-2028)
Figure 39. Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 41. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 42. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2028)
Figure 43. North America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2028)
Figure 44. United States PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 48. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 49. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2028)
Figure 50. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2028)
Figure 51. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2028)
Figure 60. China PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 67. South America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 68. South America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2028)
Figure 69. South America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2028)
Figure 70. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2028)
Figure 76. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa PD-1 and PD-L1 Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Monoclonal Antibody in 2021
Figure 81. Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody
Figure 82. PD-1 and PD-L1 Monoclonal Antibody Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のPD-1＆PD-L1モノクローナル抗体市場2022年：PD-1、 PD-L1(Global PD-1 and PD-L1 Monoclonal Antibody Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のPD-1＆PD-L1モノクローナル抗体市場2022年：PD-1、 PD-L1

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp